Bridgewater Associates »

Viking Therapeutics shares owned by Bridgewater Associates

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by Bridgewater Associates from 13F filings

Historical chart of Bridgewater Associates investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by Bridgewater Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by Bridgewater Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.2M 124k 26.28

More positions owned by Bridgewater Associates

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
salesforce (CRM)
NVIDIA Corporation (NVDA)
Lam Research Corp Com New (LRCX)
Adobe Systems Incorporated (ADBE)
Booking Holdings (BKNG)
Ge Vernova (GEV)
Uber Technologies (UBER)
Johnson & Johnson (JNJ)
Meta Platforms Cl A (META)
Advanced Micro Devices (AMD)
Sea Sponsord Ads (SE)

View all positions for Bridgewater Associates

Top funds holding Viking Therapeutics

Vanguard Group
Susquehanna International
FMR
BlackRock
State Street Corporation
Citadel Advisors
Morgan Stanley
Jpmorgan Chase & Co
Ameriprise Financial
Two Sigma Investments
Jane Street
Geode Capital Management
Two Sigma Advisers
UBS Group
Pictet Asset Management Holding SA

View all funds holding Viking Therapeutics